Myeloproliferative Neoplasm-Blast Phase (MPN- BP) has poor outcome with overall survival (OS) <6 months (mo), and limited responses to intensive chemotherapy. Venetoclax (VEN) plus hypometilating agents, effective in unfit or relapsed/refractory de-novo AML, is increasingly considered for MPN-BP. However, MPN-BP’s distinct molecular profile may not be adequately captured by current risk models (ELN24/mPRS, ELN24-refined). Aim: To define a prognostic risk profile using clinical data from ENABLE, a phase 2 trial exploring VEN and decitabine in MPN-BP

B07 | Molecular risk profiling in myeloproliferative neoplasms blast phase treated with venetoclax and decitabine: a three-gene score for survival prediction / Crupi, F.. - In: HAEMATOLOGICA. - ISSN 1592-8721. - ELETTRONICO. - 111:(2026), pp. 0-0. [10.3324/haematol.2026.s1.15]

B07 | Molecular risk profiling in myeloproliferative neoplasms blast phase treated with venetoclax and decitabine: a three-gene score for survival prediction

Crupi Francesca;A. M. Vannucchi
2026

Abstract

Myeloproliferative Neoplasm-Blast Phase (MPN- BP) has poor outcome with overall survival (OS) <6 months (mo), and limited responses to intensive chemotherapy. Venetoclax (VEN) plus hypometilating agents, effective in unfit or relapsed/refractory de-novo AML, is increasingly considered for MPN-BP. However, MPN-BP’s distinct molecular profile may not be adequately captured by current risk models (ELN24/mPRS, ELN24-refined). Aim: To define a prognostic risk profile using clinical data from ENABLE, a phase 2 trial exploring VEN and decitabine in MPN-BP
2026
111
0
0
Crupi, Francesca, A.M. Vannucchi
File in questo prodotto:
File Dimensione Formato  
13210-Article Text-90435-1-10-20260304.pdf

accesso aperto

Tipologia: Pdf editoriale (Version of record)
Licenza: Open Access
Dimensione 506.94 kB
Formato Adobe PDF
506.94 kB Adobe PDF

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1500344
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact